Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction

Por Leo, Chen-Huei, Woodman, Owen L.
Publicado no J Cardiovasc Pharmacol (2015)

3′,4′-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries

Por Leo, Chen-Huei, Hart, Joanne L., Woodman, Owen L.
Publicado em 2011

Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin‐2) Causes Rapid and Sustained Bradykinin‐Mediated Vasorelaxation

Por Leo, Chen Huei, Jelinic, Maria, Parkington, Helena C., Tare, Marianne, Parry, Laura J.
Publicado em 2014

A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of Male Mice

Por Leo, Chen Huei, Jelinic, Maria, Gooi, Jon H., Tare, Marianne, Parry, Laura J.
Publicado em 2014

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes

Por Ng, Hooi Hooi, Leo, Chen Huei, Prakoso, Darnel, Qin, Chengxue, Ritchie, Rebecca H., Parry, Laura J.
Publicado no Sci Rep (2017)

Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance

Por Leo, Chen Huei, Fernando, Dhanushke T., Tran, Lillie, Ng, Hooi Hooi, Marshall, Sarah A., Parry, Laura J.
Publicado no Front Pharmacol (2017)

Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment

Por Jelinic, Maria, Leo, Chen-Huei, Uiterweer, Emiel D. Post, Sandow, Shaun L., Gooi, Jonathan H., Wlodek, Mary E., Conrad, Kirk P., Parkington, Helena, Tare, Marianne, Parry, Laura J.
Publicado em 2014

Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function

Por Ritchie, Rebecca H., Leo, Chen Huei, Qin, Chengxue, Stephenson, Erin J., Bowden, Marissa A., Buxton, Keith D., Lessard, Sarah J., Rivas, Donato A., Koch, Lauren G., Britton, Steven L., Hawley, John A., Woodman, Owen L.
Publicado em 2013